ReviewInternational immunopharmacology2022

An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).

Reza Elahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.